Clinical trial
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups…
NCT00165659 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00165659 |
|---|---|
| Title | A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | DONEPEZIL HYDROCHLORIDE |
| Start date | Nov 1, 2002 |
| Primary completion | May 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 29, 2010 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: